Serum branch-chained amino acids are increased in type 2 diabetes and associated with atherosclerotic cardiovascular disease

• Published in: Cardiovascular diabetology Vol. 22; no. 1; pp. 1 - 10
• Main Authors: Moreno-Vedia, Juan, Llop, Dídac, Rodríguez-Calvo, Ricardo, Plana, Núria, Amigó, Núria, Rosales, Roser, Esteban, Yaiza, Girona, Josefa, Masana, Lluís, Ibarretxe, Daiana
• Format: Journal Article
• Language: English
• Published: London BioMed Central 14-09-2023; BMC
• Subjects: Alanine; Arteriosclerosis; Biomarkers; Body mass index; Cardiovascular diseases; Diabetes mellitus (non-insulin dependent); Inflammation; Insulin resistance; Isoleucine; Metabolic disorders; Metabolites; NMR; Nuclear magnetic resonance; Patients; Plasma levels; Spectrum analysis; Valine; Spain
• ISSN: 1475-2840; 1475-2840
• DOI: 10.1186/s12933-023-01958-6

Background and aimCirculating biomarkers of metabolic and cardiovascular diseases can help in the early detection and prevention of those diseases. Using proton nuclear magnetic resonance (1H-NMR), we aimed to study the plasma levels of low-molecular-weight metabolites (LMWMs) in a cohort of 307 patients with metabolic diseases to assess their relationships with type-2 diabetes (T2D) and incident atherosclerotic cardiovascular disease (ASCVD).MethodsWe conducted a cross-sectional and prospective study. We included 307 patients attending the Lipid Unit of our University Hospital for the treatment of the following metabolic disturbances and associated disorders: T2D (73.9%), obesity (58.7%), and hypertension (55.1%). 1H-NMR was used to study the plasma levels of 13 LMWMs. LMWM serum concentrations were evaluated in patients with and without T2D. and the correlations with several parameters and their associations with T2D were analyzed. The association between LMWM levels at baseline and the development of ASCVD in patients with T2D after 10 years of follow-up was also evaluated.ResultsAmong the LMWMs measured, the branched-chain amino acids (BCAAs) valine, leucine and isoleucine showed a positive association with several clinical and lipid-related biochemical parameters and inflammatory markers (p < 0.05). Likewise, these three BCAAS were associated with diabetes even after adjusting for covariates (p < 0.05). During the follow-up period of 10 years, 29 of the 185 patients with diabetes at baseline (15.68%) developed ASCVD. After adjusting for clinical covariates, baseline levels of valine and alanine were associated with the development of ASCVD (p < 0.05).ConclusionOverall, our results indicated that plasma levels of LMWMs measured by 1H-NMR could be potential biomarkers associated with T2D. Moreover, alanine and valine can help in the early detection of the cardiovascular risk associated with this metabolic disease.